Delcath Systems (DCTH) Misses Q2 EPS by 12c

Go back to Delcath Systems (DCTH) Misses Q2 EPS by 12c

Delcath Systems (DCTH) PT Raised to $20 at BTIG

August 6, 2024 4:57 AM UTC

BTIG analyst Marie Thibault raised the price target on Delcath Systems (NASDAQ: DCTH) to $20.00 (from $16.00) while maintaining a Buy rating.

The analyst comments "The U.S. commercial launch is ramping quicker than we initially expected with Delcath Systems reporting total Q2 sales of $7.8M, including $6.6M from Hepzato and $1.2M from OUS Chemosat sales. This was well above consensus of $5.2M. Seven treating centers were active in the quarter, performing what we estimate were 36 combined... More